| Name | prostaglandin E1 |
|---|---|
| Synonyms |
11,15-DIHYDROXY-9-OXOPROST-13-EN-1-OIC ACID
3-HYDROXY-2-(3-HYDROXY-1-OCTENYL)-5-OXO-CYCLOPENTANEHTANOIC ACID l-cyclopentanehtanoicaci (11ALPHA,13E,15S)-11,15-DIHYDROXY-9-OXOPROST-13-ENOIC ACID (11A,13E,15S)-11,15-DIHYDROXY-9-OXO-PROST-13-EN-1-OIC ACID Alprostadil (PGE1) Alprostadil(Prostaglandin E1) 7-{(1R,2R,3R)-3-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopentyl}heptanoic acid Prostaglandin E1 Solution, 100ppm 7-((1R,2R,3R)-3-Hydroxy-2-((S,E)-3-hydroxyoct-1-en-1-yl)-5-oxocyclopentyl)htanoic acid prostine VR 11,15-dihydroxy-9-oxo-,(11-alpha,13e,15s)-prost-13-en-1-oicaci 11α,15α-Dihydroxy-9-oxo-13-trans-prostenoic acid (1R,2R,3R)-3-Hydroxy-2-((E)-(3S)-3-hydroxy-1-octenyl)-5-oxocyclopentanehtanoic acid l-pge1 Prostaglandin E1 or AIPROSTADIL 11α,15(S)-Dihydroxy-9-oxo-13-trans-prostenoic acid [11ALPHA,13E,15S]-11,15-DIHYDROXY-9-OXOPROST-13-EN-1-OIC ACID EINECS 212-017-2 (11α,13E,15S)-11,15-Dihydroxy-9-oxoprost-13-enoic acid, Alprostadil, PGE1, Prostaglandin E1 ProstaglandinE1 Minprog Alprostadil (25 mg) ALPROSTADIL Alprostadil Prostaglandin E1 Powder l-protaglandine1 (8S,11S,12S,13E,15R)-11,15-Dihydroxy-9-oxoprost-13-en-1-oic acid Alprostadil (prostandin E1) (-)-protaglandine1 ent-PGE1 cGMP Alprostadil Prostandin Prost-13-en-1-oic acid (11a,13E,15S)-11,15-Dihydroxy-9-oxoprost-13-en-1-oic Acid l-3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentanehtanoicacid Alprostadil(Caverject) Cyclopentanehtanoic acid, 3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-, l 9-OXO-11ALPHA,15S-DIHYDROXY-PROST-13E-EN-1-OIC ACID Cyclopentanehtanoic acid, 3α-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo- (7CI) Palux Liple Prostaglandin E1 Analytical Reference Standd Prostaglandin E1 (PGE1) (11α,13e,15s)-11,15-dihydroxy-9-oxoprost-13-enoic acid (1R,2R,3R)-3-Hydroxy-2-((E)-(3S)-3-hydroxy-1-octenyl)-5-oxocyclopentaneheptanoic acid Caveject (11α,13E,15S)-11,15-Dihydroxy-9-oxoprost-13-enoic acid, Alprostadil, PGE1 7-[3-hydroxy-2-(3-hydroxyoct-1-enyl)-5-oxo-cyclopentyl]htanoic acid Prost-13-en-1-oic acid, 11,15-dihydroxy-9-oxo-, (11a,13E,15S) MFCD00077860 PGEl Alprostadil lyophilized liposoMal Lipoprost [11ALPHA,13E,15S]-11,15-DIHYDROXY-9-OXOPROSTA-13-EN-1-OIC ACID l-Prostaglandin E1 (11α, 13E, 15S)-11, 15-dihydroxy-9-oxyprosta-13-en-1-oic acid Prostaglandine E PGE1 l-Cyclopentanehtanoic PegE1 Topiglan Cyclopentanehtanoic acid, 3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-, (-)- (8CI) Alprox TD 11,15-dihydroxy-9-oxo-, (11α,13E,15S)-prost-13-en-1-oic acid (11α,13E,15S)-11,15-Dihydroxy-9-oxo-prost-13-en-1-oicacid alprostadil (11a,13E,15S)-11,15-Dihydroxy-9-oxo-prost-13-en-1-oic acid (11α,13E,15S)-11,15-Dihydroxy-9-oxoprost-13-en-1-oic acid Liprostin ONO 1608 Caverject Alprostadil (PGE1)/Prostaglandin E1 |
| Description | Prostaglandin E1 (PGE1) is a potent vasodilator and activates the prostaglandin E1 (EP) receptor. |
|---|---|
| Related Catalog | |
| Target |
Human Endogenous Metabolite |
| References |
| Density | 1.1±0.1 g/cm3 |
|---|---|
| Boiling Point | 529.3±50.0 °C at 760 mmHg |
| Melting Point | 115-116 °C |
| Molecular Formula | C20H34O5 |
| Molecular Weight | 354.481 |
| Flash Point | 288.0±26.6 °C |
| Exact Mass | 354.240631 |
| PSA | 94.83000 |
| LogP | 2.24 |
| Vapour Pressure | 0.0±3.2 mmHg at 25°C |
| Index of Refraction | 1.546 |
| Storage condition | -20℃ |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
MUTATION DATA
|
| Symbol |
GHS06, GHS08 |
|---|---|
| Signal Word | Danger |
| Hazard Statements | H301-H361 |
| Precautionary Statements | P281-P301 + P310 |
| Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Faceshields;Gloves |
| Hazard Codes | Xn:Harmful |
| Risk Phrases | R22 |
| Safety Phrases | 36-26 |
| RIDADR | UN 2811 6.1/PG 3 |
| WGK Germany | 3 |
| RTECS | GY4569800 |
| Packaging Group | III |
| Hazard Class | 6.1(b) |
| HS Code | 29375000 |
| Precursor 3 | |
|---|---|
| DownStream 0 | |
| HS Code | 29375000 |
|---|